Legal & General Group
PVLA

Legal & General Group’s Palvella Therapeutics PVLA Stock Holding History

Legal & General Group’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$928K Buy
7,446
+1,597
+27% +$167K ﹤0.01% 2167
2025
Q4 		$612K Buy
5,849
+5,094
+675% +$435K ﹤0.01% 2357
2025
Q3 		$47.3K Hold
755
– – ﹤0.01% 2746
2025
Q2 		$17K Buy
+755
New +$17.7K ﹤0.01% 3078
2021
Q3 		– Sell
-27
Closed -$8K – 3515
2021
Q2 		$8K Sell
27
-42
-61% -$9.21K ﹤0.01% 3442
2021
Q1 		$14K Sell
69
-9
-12% -$1.97K ﹤0.01% 3287
2020
Q4 		$16K Hold
78
– – ﹤0.01% 3182
2020
Q3 		$13K Sell
78
-19
-20% -$4.33K ﹤0.01% 3138
2020
Q2 		$24K Hold
97
– – ﹤0.01% 2992
2020
Q1 		$16K Sell
97
-22
-18% -$5.54K ﹤0.01% 3005
2019
Q4 		$35K Buy
119
+22
+23% +$6.1K ﹤0.01% 2981
2019
Q3 		$26K Hold
97
– – ﹤0.01% 3041
2019
Q2 		$34K Hold
97
– – ﹤0.01% 2955
2019
Q1 		$26K Hold
97
– – ﹤0.01% 3000
2018
Q4 		$21K Hold
97
– – ﹤0.01% 3064
2018
Q3 		$43K Hold
97
– – ﹤0.01% 2854
2018
Q2 		$39K Buy
97
+15
+18% +$7.14K ﹤0.01% 2879
2018
Q1 		$45K Hold
82
– – ﹤0.01% 2805
2017
Q4 		$50K Buy
82
+18
+28% +$8.37K ﹤0.01% 2863
2017
Q3 		$29K Hold
64
– – ﹤0.01% 3072
2017
Q2 		$26K Buy
+64
New +$18.7K ﹤0.01% 3087

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legal & General Group's PVLA Position: Q1 2026 in Review

Legal & General Group increased its Palvella Therapeutics (PVLA) stake by 27% in Q1 2026, buying an estimated $167K and bringing the position to 7,446 shares worth $928K. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Legal & General Group first reported a position in PVLA in Q2 2017 and has held it in 21 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Legal & General Group held 7,446 shares of Palvella Therapeutics worth $928K as of Q1 2026.
  • Legal & General Group bought 1,597 Palvella Therapeutics shares in Q1 2026, an estimated $167K.
  • Palvella Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2167 holding.
  • Legal & General Group first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 21 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.